{"id":"https://openalex.org/W1967051322","doi":"https://doi.org/10.1111/j.1365-2141.2007.06852.x","title":"TRAIL signals to apoptosis in chronic lymphocytic leukaemia cells primarily through TRAIL\u2010R1 whereas cross\u2010linked agonistic TRAIL\u2010R2 antibodies facilitate signalling via TRAIL\u2010R2","display_name":"TRAIL signals to apoptosis in chronic lymphocytic leukaemia cells primarily through TRAIL\u2010R1 whereas cross\u2010linked agonistic TRAIL\u2010R2 antibodies facilitate signalling via TRAIL\u2010R2","publication_year":2007,"publication_date":"2007-10-08","ids":{"openalex":"https://openalex.org/W1967051322","doi":"https://doi.org/10.1111/j.1365-2141.2007.06852.x","mag":"1967051322","pmid":"https://pubmed.ncbi.nlm.nih.gov/17922877"},"language":"en","primary_location":{"id":"doi:10.1111/j.1365-2141.2007.06852.x","doi":"https://doi.org/10.1111/j.1365-2141.2007.06852.x","is_oa":true,"landing_page_url":"https://doi.org/10.1111/j.1365-2141.2007.06852.x","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1365-2141.2007.06852.x","source":{"id":"https://openalex.org/S153015021","display_name":"British Journal of Haematology","issn_l":"0007-1048","issn":["0007-1048","1365-2141"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Haematology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1365-2141.2007.06852.x","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5056680282","display_name":"Alessandro Natoni","orcid":"https://orcid.org/0000-0003-4321-9005","observed_orcids":["https://orcid.org/0000-0003-4321-9005"]},"institutions":[{"id":"https://openalex.org/I153648349","display_name":"University of Leicester","ror":"https://ror.org/04h699437","country_code":"GB","type":"education","lineage":["https://openalex.org/I153648349"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Alessandro Natoni","raw_affiliation_strings":["MRC Toxicology Unit, University of Leicester, Leicester, UK","These authors contributed equally to this study"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"MRC Toxicology Unit, University of Leicester, Leicester, UK","institution_ids":["https://openalex.org/I153648349"]},{"raw_affiliation_string":"These authors contributed equally to this study","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034035769","display_name":"Marion MacFarlane","orcid":"https://orcid.org/0000-0001-7886-1159","observed_orcids":["https://orcid.org/0000-0001-7886-1159"]},"institutions":[{"id":"https://openalex.org/I153648349","display_name":"University of Leicester","ror":"https://ror.org/04h699437","country_code":"GB","type":"education","lineage":["https://openalex.org/I153648349"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Marion MacFarlane","raw_affiliation_strings":["MRC Toxicology Unit, University of Leicester, Leicester, UK","These authors contributed equally to this study"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"MRC Toxicology Unit, University of Leicester, Leicester, UK","institution_ids":["https://openalex.org/I153648349"]},{"raw_affiliation_string":"These authors contributed equally to this study","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5024548116","display_name":"Satoshi Inoue","orcid":"https://orcid.org/0000-0003-1247-3844","observed_orcids":["https://orcid.org/0000-0003-1247-3844"]},"institutions":[{"id":"https://openalex.org/I153648349","display_name":"University of Leicester","ror":"https://ror.org/04h699437","country_code":"GB","type":"education","lineage":["https://openalex.org/I153648349"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Satoshi Inoue","raw_affiliation_strings":["MRC Toxicology Unit, University of Leicester, Leicester, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"MRC Toxicology Unit, University of Leicester, Leicester, UK","institution_ids":["https://openalex.org/I153648349"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004152600","display_name":"Renata J. Walewska","orcid":"https://orcid.org/0009-0007-5693-2789","observed_orcids":["https://orcid.org/0009-0007-5693-2789"]},"institutions":[{"id":"https://openalex.org/I153648349","display_name":"University of Leicester","ror":"https://ror.org/04h699437","country_code":"GB","type":"education","lineage":["https://openalex.org/I153648349"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Renata Walewska","raw_affiliation_strings":["MRC Toxicology Unit, University of Leicester, Leicester, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"MRC Toxicology Unit, University of Leicester, Leicester, UK","institution_ids":["https://openalex.org/I153648349"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113630709","display_name":"Aneela Majid","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I153648349","display_name":"University of Leicester","ror":"https://ror.org/04h699437","country_code":"GB","type":"education","lineage":["https://openalex.org/I153648349"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Aneela Majid","raw_affiliation_strings":["MRC Toxicology Unit, University of Leicester, Leicester, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"MRC Toxicology Unit, University of Leicester, Leicester, UK","institution_ids":["https://openalex.org/I153648349"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015764873","display_name":"Deborah A. Knee","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I127128434","display_name":"Genomics Institute of the Novartis Research Foundation","ror":"https://ror.org/017136v53","country_code":"US","type":"facility","lineage":["https://openalex.org/I127128434","https://openalex.org/I1283582996","https://openalex.org/I4210117619"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Deborah Knee","raw_affiliation_strings":["Novartis Institute for Functional Genomics, Inc. San Diego, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Novartis Institute for Functional Genomics, Inc. San Diego, CA, USA","institution_ids":["https://openalex.org/I127128434"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072189533","display_name":"David R. Stover","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"David R. Stover","raw_affiliation_strings":["Novartis Institutes for Biomedical Research, Oncology Department, Cambridge, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Novartis Institutes for Biomedical Research, Oncology Department, Cambridge, MA, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5081516283","display_name":"Martin J.S. Dyer","orcid":"https://orcid.org/0000-0002-5033-2236","observed_orcids":["https://orcid.org/0000-0002-5033-2236"]},"institutions":[{"id":"https://openalex.org/I153648349","display_name":"University of Leicester","ror":"https://ror.org/04h699437","country_code":"GB","type":"education","lineage":["https://openalex.org/I153648349"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Martin J. S. Dyer","raw_affiliation_strings":["MRC Toxicology Unit, University of Leicester, Leicester, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"MRC Toxicology Unit, University of Leicester, Leicester, UK","institution_ids":["https://openalex.org/I153648349"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5109195950","display_name":"Gerald M. Cohen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I153648349","display_name":"University of Leicester","ror":"https://ror.org/04h699437","country_code":"GB","type":"education","lineage":["https://openalex.org/I153648349"]}],"countries":["GB"],"is_corresponding":true,"raw_author_name":"Gerald M. Cohen","raw_affiliation_strings":["MRC Toxicology Unit, University of Leicester, Leicester, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"MRC Toxicology Unit, University of Leicester, Leicester, UK","institution_ids":["https://openalex.org/I153648349"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5109195950"],"corresponding_institution_ids":["https://openalex.org/I153648349"],"apc_list":{"value":5190,"currency":"USD","value_usd":5190},"apc_paid":null,"fwci":2.6113,"has_fulltext":false,"cited_by_count":70,"citation_normalized_percentile":{"value":0.90443956,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":87,"max":98},"biblio":{"volume":"139","issue":"4","first_page":"568","last_page":"577"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10294","display_name":"Cell death mechanisms and regulation","score":0.9320999979972839,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10294","display_name":"Cell death mechanisms and regulation","score":0.9320999979972839,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":0.060600001364946365,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10583","display_name":"Cancer-related Molecular Pathways","score":0.0005000000237487257,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/trail","display_name":"TRAIL","score":0.9950000047683716},{"id":"https://openalex.org/keywords/trail-r1","display_name":"TRAIL-R1","score":0.8880000114440918},{"id":"https://openalex.org/keywords/dr5","display_name":"DR5","score":0.9980000257492065},{"id":"https://openalex.org/keywords/chronic-lymphocytic-leukemia","display_name":"chronic lymphocytic leukemia","score":0.9940000176429749},{"id":"https://openalex.org/keywords/apoptosis-signaling-pathway","display_name":"apoptosis signaling","score":0.746999979019165},{"id":"https://openalex.org/keywords/agonistic-monoclonal-antibody","display_name":"agonistic monoclonal antibody","score":0.8809999823570251},{"id":"https://openalex.org/keywords/antibody-cross-linking","display_name":"antibody cross-linking","score":0.9490000009536743},{"id":"https://openalex.org/keywords/lexatumumab","display_name":"lexatumumab","score":0.7749999761581421},{"id":"https://openalex.org/keywords/mapatumumab","display_name":"mapatumumab","score":0.9779999852180481},{"id":"https://openalex.org/keywords/histone-deacetylase-inhibitors","display_name":"histone deacetylase inhibitors","score":0.8650000095367432},{"id":"https://openalex.org/keywords/lymphoid-malignancies","display_name":"lymphoid malignancies","score":0.6679999828338623}],"concepts":[{"id":"https://openalex.org/C190283241","wikidata":"https://www.wikidata.org/wiki/Q14599311","display_name":"Apoptosis","level":2,"score":0.6793891191482544},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.5865910649299622},{"id":"https://openalex.org/C187898756","wikidata":"https://www.wikidata.org/wiki/Q395324","display_name":"Agonistic behaviour","level":3,"score":0.553157389163971},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.528526782989502},{"id":"https://openalex.org/C17991360","wikidata":"https://www.wikidata.org/wiki/Q21173843","display_name":"Tumor necrosis factor alpha","level":2,"score":0.5219035744667053},{"id":"https://openalex.org/C2777938653","wikidata":"https://www.wikidata.org/wiki/Q1088156","display_name":"Chronic lymphocytic leukemia","level":3,"score":0.5200976133346558},{"id":"https://openalex.org/C542903549","wikidata":"https://www.wikidata.org/wiki/Q422248","display_name":"Monoclonal antibody","level":3,"score":0.5095860958099365},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.508344829082489},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.36910876631736755},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.3637901544570923},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.2424950897693634},{"id":"https://openalex.org/C2778461978","wikidata":"https://www.wikidata.org/wiki/Q29496","display_name":"Leukemia","level":2,"score":0.2282629907131195},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.06719046831130981},{"id":"https://openalex.org/C2779448149","wikidata":"https://www.wikidata.org/wiki/Q191797","display_name":"Aggression","level":2,"score":0.0},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000077767","descriptor_name":"Panobinostat","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000369","descriptor_name":"Aged, 80 and over","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D002450","descriptor_name":"Cell Communication","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D003432","descriptor_name":"Cross-Linking Reagents","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004347","descriptor_name":"Drug Interactions","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006877","descriptor_name":"Hydroxamic Acids","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D007211","descriptor_name":"Indoles","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015451","descriptor_name":"Leukemia, Lymphocytic, Chronic, B-Cell","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D015451","descriptor_name":"Leukemia, Lymphocytic, Chronic, B-Cell","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D017209","descriptor_name":"Apoptosis","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D036342","descriptor_name":"Ephrins","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":true},{"descriptor_ui":"D045744","descriptor_name":"Cell Line, Tumor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D053220","descriptor_name":"Receptors, TNF-Related Apoptosis-Inducing Ligand","qualifier_ui":"Q000819","qualifier_name":"agonists","is_major_topic":true},{"descriptor_ui":"D053221","descriptor_name":"TNF-Related Apoptosis-Inducing Ligand","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":true},{"descriptor_ui":"D058846","descriptor_name":"Antibodies, Monoclonal, Murine-Derived","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D058846","descriptor_name":"Antibodies, Monoclonal, Murine-Derived","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false}],"locations_count":6,"locations":[{"id":"doi:10.1111/j.1365-2141.2007.06852.x","doi":"https://doi.org/10.1111/j.1365-2141.2007.06852.x","is_oa":true,"landing_page_url":"https://doi.org/10.1111/j.1365-2141.2007.06852.x","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1365-2141.2007.06852.x","source":{"id":"https://openalex.org/S153015021","display_name":"British Journal of Haematology","issn_l":"0007-1048","issn":["0007-1048","1365-2141"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Haematology","raw_type":"journal-article"},{"id":"pmid:17922877","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/17922877","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British journal of haematology","raw_type":"Journal Article"},{"id":"pmh:oai:figshare.com:article/10080260","doi":null,"is_oa":false,"landing_page_url":"https://figshare.com/articles/journal_contribution/TRAIL_signals_to_apoptosis_in_CLL_cells_primarily_through_TRAIL_R-1_whereas_cross-linked_agonistic_TRAIL_R-2_antibodies_facilitate_signalling_via_TRAIL_R-2/10080260","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"Text"},{"id":"pmh:oai:iris.uniroma1.it:11573/1673694","doi":null,"is_oa":false,"landing_page_url":"https://hdl.handle.net/11573/1673694","pdf_url":null,"source":{"id":"https://openalex.org/S4377196107","display_name":"IRIS Research product catalog (Sapienza University of Rome)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:lra.le.ac.uk:2381/4123","doi":null,"is_oa":false,"landing_page_url":"http://onlinelibrary.wiley.com/doi/10.1111/j.1365-2141.2007.06852.x/abstract","pdf_url":null,"source":{"id":"https://openalex.org/S4306402365","display_name":"Leicester Research Archive (University of Leicester)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I153648349","host_organization_name":"University of Leicester","host_organization_lineage":["https://openalex.org/I153648349"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"Article"},{"id":"mag:2519600348","doi":null,"is_oa":false,"landing_page_url":"https://lra.le.ac.uk/bitstream/2381/4123/1/Final%20CLL%20Xlink%20Aug%208%20%20BJH.pdf","pdf_url":null,"source":null,"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null}],"best_oa_location":{"id":"doi:10.1111/j.1365-2141.2007.06852.x","doi":"https://doi.org/10.1111/j.1365-2141.2007.06852.x","is_oa":true,"landing_page_url":"https://doi.org/10.1111/j.1365-2141.2007.06852.x","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1365-2141.2007.06852.x","source":{"id":"https://openalex.org/S153015021","display_name":"British Journal of Haematology","issn_l":"0007-1048","issn":["0007-1048","1365-2141"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Haematology","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9476000070571899,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W1967051322.pdf"},"referenced_works_count":26,"referenced_works":["https://openalex.org/W1594149454","https://openalex.org/W1602157480","https://openalex.org/W1967894078","https://openalex.org/W1973848893","https://openalex.org/W1974144614","https://openalex.org/W1979639369","https://openalex.org/W1986938005","https://openalex.org/W1997005484","https://openalex.org/W2003054861","https://openalex.org/W2016770760","https://openalex.org/W2016979416","https://openalex.org/W2025128734","https://openalex.org/W2038118195","https://openalex.org/W2041986555","https://openalex.org/W2044360617","https://openalex.org/W2056031584","https://openalex.org/W2064216603","https://openalex.org/W2067298582","https://openalex.org/W2069875612","https://openalex.org/W2077703166","https://openalex.org/W2109463067","https://openalex.org/W2114468318","https://openalex.org/W2118971842","https://openalex.org/W2168455351","https://openalex.org/W2327001242","https://openalex.org/W2328332463"],"related_works":["https://openalex.org/W2519600348","https://openalex.org/W2077703166","https://openalex.org/W2118971842","https://openalex.org/W1989738561","https://openalex.org/W6983415447","https://openalex.org/W2008465548","https://openalex.org/W2588870051","https://openalex.org/W2513909258","https://openalex.org/W1594865953","https://openalex.org/W1996670401"],"abstract_inverted_index":{"Tumour":[0],"necrosis":[1],"factor":[2],"(TNF)-related":[3],"apoptosis-inducing":[4],"ligand":[5],"(TRAIL),":[6],"a":[7],"member":[8],"of":[9,48,66,136,165,194],"the":[10,129,137,163,191],"TNF":[11],"family,":[12],"which":[13],"is":[14,187],"being":[15],"developed":[16],"as":[17,50,52,158,202],"an":[18],"anti-tumour":[19],"agent":[20],"due":[21],"to":[22,26,33,56,79,83,98,114,126],"its":[23],"selective":[24],"toxicity":[25],"tumour":[27,183],"cells,":[28],"induces":[29],"apoptosis":[30,99,127],"by":[31,150],"binding":[32],"two":[34],"membrane-bound":[35],"receptors,":[36],"TRAIL-R1":[37,57,149,178],"and":[38,58,142,179],"TRAIL-R2.":[39,59],"Clinical":[40],"trials":[41],"have":[42],"been":[43],"initiated":[44],"with":[45,73],"various":[46,87],"preparations":[47],"TRAIL":[49,84,89,195],"well":[51],"agonistic":[53,107,138,155],"monoclonal":[54],"antibodies":[55,109],"Previously":[60],"we":[61,92],"reported":[62],"that":[63,94,121],"prior":[64],"treatment":[65],"primary":[67,182,198],"chronic":[68],"lymphocytic":[69],"leukaemia":[70],"(CLL)":[71],"cells":[72,82,96,123],"histone":[74],"deacetylase":[75],"inhibitors":[76],"was":[77],"required":[78],"sensitize":[80],"CLL":[81,95,122],"and,":[85],"using":[86],"receptor-selective":[88,151],"mutant":[90],"ligands,":[91],"demonstrated":[93,120],"signalled":[97],"primarily":[100],"through":[101,128,148,177],"TRAIL-R1.":[102],"Some,":[103],"but":[104,132],"not":[105],"all,":[106],"TRAIL-receptor":[108],"require":[110],"cross-linking":[111,135],"in":[112,162,173,181,197],"order":[113],"induce":[115],"apoptosis.":[116],"The":[117],"present":[118],"study":[119],"can":[124],"signal":[125],"TRAIL-R2":[130,139,180],"receptor,":[131],"only":[133],"after":[134],"antibodies,":[140,156],"LBY135":[141],"lexatumumab":[143],"(HGS-ETR2).":[144],"In":[145],"contrast,":[146],"signalling":[147,175],"ligands":[152],"or":[153],"certain":[154],"such":[157,201],"mapatumumab":[159],"(HGS-ETR1),":[160],"occurs":[161],"absence":[164],"cross-linking.":[166],"These":[167],"results":[168],"further":[169],"highlight":[170],"important":[171,189],"differences":[172],"apoptotic":[174],"triggered":[176],"cells.":[184],"Such":[185],"information":[186],"clearly":[188],"for":[190],"rational":[192],"optimisation":[193],"therapy":[196],"lymphoid":[199],"malignancies,":[200],"CLL.":[203]},"counts_by_year":[{"year":2025,"cited_by_count":2},{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2019,"cited_by_count":2},{"year":2018,"cited_by_count":3},{"year":2017,"cited_by_count":3},{"year":2016,"cited_by_count":5},{"year":2015,"cited_by_count":5},{"year":2014,"cited_by_count":6},{"year":2013,"cited_by_count":5},{"year":2012,"cited_by_count":5}],"updated_date":"2026-11-12T12:28:57.059296","created_date":"2016-06-24T00:00:00"}